460
Phenotype Analysis of HIV-1 Envelopes Amplified from Brain and Lymph Node Tissue of AIDS Patients with Neuropathology Identifies Envelopes with an Enhanced Tropism and Fusigenicity for Macrophages
P Peters*1, J Bhattacharya1, S Hibbitts2, M Dittmar3, G Simmons4, J Bell5, P Simmonds6, and P Clapham1
1Univ. of Massachusetts Med. Sch., Worcester, USA; 2Univ. of Wales Coll. of Med., Cardiff, UK; 3Hygiene-Inst, Heidelberg, Germany; 4Univ. of Pennsylvania, Philadelphia, USA; 5Western Gen. Hosp., Edinburgh, Scotland; and 6Univ. of Edinburgh, Scotland
Background: HIV-1
replication in the brain results in AIDS dementia complex in about 30% of AIDS
patients. The mechanisms that lead to neuropathogenesis are unclear. Also it is
not known whether neurotropic or neurovirulent HIV-1 variants are involved. Others
reported HIV-1 isolates with enhanced tropism and fusigenicity for macrophages.
Here we used PCR to recover
complete envelope (env) genes from
brain tissue of 5 patients with AIDS dementia complex. These env have not been altered by culture
during isolation. The biological properties of these env were then investigated.
Methods: Complete env genes were amplified from autopsy
brain tissue of the 5 patients and lymph node tissue of 2 of these patients.
All env were cloned into the pSVIIIenv expression vector; 293T cells were
co-transfected with env+ pSVIIIenv and env- NL43 and pseudotype virus harvested. Single-round
infectivity assays were conducted on co-receptor+ indicator cells
and on macrophages. Sensitivities to CCR5
inhibitor TAK779 and CD4 specific antibody Q4120 were tested on GHOST/CCR5. The effects of receptor density were assessed
by single-round infectivity assays on HeLa clones expressing various amounts of
CD4 and CCR5.
Results: From the 5 patients,
19 env had distinct V1V2 sequences.
Of these, 13 env were functional and
conferred infectivity for CD4+ CCR5+
cells. Infectivity and cell:cell fusion assays showed that most env used both CCR5
and CCR3. One env used a broad range of co-receptors, while several were
restricted to CCR5. There was no
correlation between tissue of origin and co-receptor use. Env that were highly fusigenic and tropic for macrophages were
identified in brain tissue from 4 of 5 patients. These env were at the top limit of macrophage tropism when compared to a
panel of well-characterized macrophage tropic control env. The enhanced macrophage-tropism correlated with sensitivity to
inhibition by the CD4-specific antibody Q4120 but not with sensitivity to the CCR5 inhibitor TAK779. The highly macrophage-tropic
env were able to infect cells
expressing low levels of CD4 or CCR5.
Conclusions: Our data show
the presence of env that are highly
fusigenic and tropic for macrophages in the brains of patients with
neurological complications. These env
are able to infect cells that express low levels of CD4 or CCR5 and may have adapted for replication in brain
macrophages and microglia that express limited amounts of CD4.
Keywords: Envelope; Tropism; Macrophage
